NEW YORK ( TheStreet) -- Welcome to Don Dion's "ETF Winners and Losers." Be sure to stop by throughout the week to find out which ETFs are gaining or losing.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
With the GDXJ seeing huge inflows, could the ETF be too big to succeed?
The good news is that consolidation could create buying opportunities.
Doug Kass shares his thoughts on Deere's February sales, and his wishes and hopes involving Twitter.